Trial Profile
A Phase 2 study of RT002 in Chronic migraine
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 24 Apr 2018
Price :
$35
*
At a glance
- Drugs Daxibotulinumtoxin A (Primary)
- Indications Migraine
- Focus Therapeutic Use
- 24 Apr 2018 New trial record
- 19 Apr 2018 According to Revance therapeutics media release, study eill initiate in 2019